Lab Information
Jesse Papenburg (MD)
ScientistCentre for Outcomes Research and Evaluation
Department of Pediatrics (McGill)
Research Profile
Keywords
Influenza • respiratory syncytial virus (RSV) • children • epidemiology • diagnosisResearch Interests
My research focuses on the epidemiology and diagnosis of severe viral lower respiratory tract infections requiring hospitalisation in children in Quebec and Canada.Team Members
| Name | Position |
|---|
Latest Publications
- Zinszer, K., Charland, K., Pierce, L., Saucier, A., Hamelin, M.-È., Da Torre, M. B., Carbonneau, J., Nguyen, C. T., De Serres, G., Papenburg, J., Boivin, G. & Quach, C. (2023). Infection-induced seroconversion and seroprevalence of SARS-CoV-2 among a cohort of children and youth in Montreal, Canada. Influenza and other respiratory viruses, vol. 17, p. e13186.
- Ramirez, K. A., Mond, J., Papenburg, J., Boivin, G., Gilbert, B. E., Falsey, A. R., Bagga, B. & DeVincenzo, J. P. (2023). In-vivo and human evidence for potential efficacy of therapeutic polyclonal RSV neutralizing antibodies for palivizumab-resistant RSV infections. Virology, vol. 586, p. 115-121.
- Alfraij, A., Abdelmoniem, A., Elseadawy, M., Surour, M., Basuni, M., Papenburg, J. & Alghounaim, M. (2023). The effect of Telehealth Antimicrobial Stewardship Program (Tele-ASP) on antimicrobial use in a pediatric intensive care unit: Pre- and post-implementation single center study. Journal of infection and public health, vol. 16, p. 1361-1367.
- Autmizguine, J., Barton, M., Burton, C., Dixit, D., Papenburg, J., Robinson, J., Top, K. A., Rubin, E. & AMMI Canada treatment of acute COVID-19 in pediatrics working group (2022). AMMI Canada Practice Point on the treatment of acute COVID-19 in pediatrics. Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada, vol. 7, p. 307-316.
- El Tal, T., Morin, M.-P., Morris, S. K., Farrar, D. S., Berard, R. A., Kakkar, F., Moore Hepburn, C., Baerg, K., Beaufils, C., Bennett, T.-L., Benseler, S. M., Beaudoin-Bussières, G., Chan, K., Cyr, C., Dahdah, N., Donner, E. J., Drouin, O., Edjoc, R., Eljaouhari, M., Embree, J. E., Farrell, C., Finzi, A., Forgie, S., Giroux, R., Kang, K. T., King, M., Laffin Thibodeau, M., Lang, B., Laxer, R. M., Luu, T. M., McCrindle, B. W., Orkin, J., Papenburg, J., Pound, C. M., Price, V. E., Proulx-Gauthier, J.-P., Purewal, R., Sadarangani, M., Salvadori, M. I., Thibeault, R., Top, K. A., Viel-Thériault, I., Haddad, E., Scuccimarri, R. & Yeung, R. S. M. (2023). Paediatric inflammatory multisystem syndrome in Canada: population-based surveillance and role of SARS-CoV-2 linkage. Pediatric research, p. 1-10.
- Hadid, A., McDonald, E. G., Cheng, M. P., Papenburg, J., Libman, M., Dixon, P. C. & Jensen, D. (2023). The WE SENSE study protocol: A controlled, longitudinal clinical trial on the use of wearable sensors for early detection and tracking of viral respiratory tract infections. Contemporary clinical trials, vol. 128, p. 107103.
- Schober, T., Morris, S. K., Bettinger, J. A., Bancej, C., Burton, C., Foo, C., Halperin, S. A., Jadavji, T., Kazmi, K., Modler, J., Sadarangani, M., Papenburg, J. & Canadian Immunization Monitoring Program Active (IMPACT) Investigators (2023). Outcomes of immunocompromised children hospitalized for Influenza, 2010-2021, the Canadian Immunization Monitoring Program Active (IMPACT). Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, vol. 29, p. 924-932.
- Paquette, M., Renaud, C. & Papenburg, J. (2023). [Not Available]. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, vol. 195, p. E531-E532.
- Zinszer, K., Charland, K., Pierce, L., Saucier, A., McKinnon, B., Hamelin, M.-È., Cheriet, I., Da Torre, M. B., Carbonneau, J., Nguyen, C. T., De Serres, G., Papenburg, J., Boivin, G. & Quach, C. (2023). Pre-Omicron seroprevalence, seroconversion, and seroreversion of infection-induced SARS-CoV-2 antibodies among a cohort of children and teenagers in Montréal, Canada. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, vol. 131, p. 119-126.
- Wilkins, D., Langedijk, A. C., Lebbink, R. J., Morehouse, C., Abram, M. E., Ahani, B., Aksyuk, A. A., Baraldi, E., Brady, T., Chen, A. T., Chi, H., Choi, E. H., Cohen, R., Danilenko, D. M., Gopalakrishnan, V., Greenough, A., Heikkinen, T., Hosoya, M., Keller, C., Kelly, E. J., Kragten-Tabatabaie, L., Martinón-Torres, F., de Los Santos, A. H. M., Nunes, M. C., Palomino, M. A., Papenburg, J., Pernica, J. M., Richmond, P., Stein, R. T., Tuffy, K. M., Verwey, C., Esser, M. T., Tabor, D. E., Bont, L. J. & INFORM-RSV Study Group (2023). Nirsevimab binding-site conservation in respiratory syncytial virus fusion glycoprotein worldwide between 1956 and 2021: an analysis of observational study sequencing data. The Lancet. Infectious diseases, vol. 23, p. 856-866.
See also
